Table 2

Immunological parameters: pre and post treatment immune marker comparison between the two groups of depressed subjects
Omega-3 group (n=22) Placebo group (n=24) Tests
Pre-treatment Post-treatment Pre-treatment Post-treatment
Mean (Std.dev.) Mean (Std.dev.) Mean (Std.dev.) Mean (Std.dev.) 1 2 3 4
CD2 84.2 (12.2) 82.9 (12.9) 88.4 (5.5) 87.9 (8.0)
CD19 9.0 (10.9) 10.6 (10.2) 6.2 (4.5) 10.9 (18.3)
CD3 66.1 (12.8) 66.5 (12.9) 69.8 (8.8) 70.6 (9.6)
CD4 41.4 (14.3) 39.1 (16.3) 44.4 (7.9) 41.4 (11.9)
CD8 31.9 (13.4) 29.1 (13.9) 29.5 (8.1) 30.9 (9.6)
CD16 13.0 (9.3) 16.5 (10.8) 12.4 (6.2) 15.0 (8.6) *
CD4/CD8 1.58 (0.96) 1.68 (1.17) 1.66 (0.85) 1.45 (0.64)
IL-5 1.69 (0.60) 1.89 (1.28) 4.36 (8.22) 3.23 (5.90)
IL-15 5.86 (3.88) 8.11 (6.14) 5.88 (3.32) 5.99 (5.41)

1 Student’s paired t-test or Wilcoxon signed-rank test to compare post-treatment to baseline values within n-3 group.

2 Student’s paired t-test or Wilcoxon signed-rank test to compare post-treatment to baseline values within placebo group.

3 Unpaired t-test or Wilcoxon rank sum test to compare baseline values between n-3 and placebo group.

4 Unpaired t-test or Wilcoxon rank sum test to compare changes from baseline values between n-3 and placebo group.

* p<0.05.

Rizzo et al.

Rizzo et al. Nutrition Journal 2012 11:82   doi:10.1186/1475-2891-11-82

Open Data